brimonidine tartrate has been researched along with gentamicin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aston, SJ; Capel, B; Capell, BC; Chiu, ES; Jelks, EB; Jelks, GW; Press, R | 1 |
Goold, LA; Nathan, F; Warrier, SK; Wittles, NK | 1 |
Bodmer, D; Cortada, M; Levano, S | 1 |
1 review(s) available for brimonidine tartrate and gentamicin
Article | Year |
---|---|
Successful management of orbital cellulitis and temporary visual loss after blepharoplasty.
Topics: Abscess; Adult; Anti-Bacterial Agents; Blepharoplasty; Blindness; Brimonidine Tartrate; Cavernous Sinus Thrombosis; Cellulitis; Clindamycin; Combined Modality Therapy; Decompression, Surgical; Dexamethasone; Drainage; Emergencies; Exophthalmos; Female; Gentamicins; Humans; Latanoprost; Nerve Compression Syndromes; Occupational Exposure; Optic Nerve Diseases; Orbital Diseases; Penicillins; Prostaglandins F, Synthetic; Quinoxalines; Streptococcal Infections; Streptococcus pyogenes; Surgical Wound Infection; Teaching; Timolol; Vancomycin; Vision Disorders | 2006 |
2 other study(ies) available for brimonidine tartrate and gentamicin
Article | Year |
---|---|
Microbial keratitis secondary to infection with Citrobacter koseri.
Topics: Aged; Anti-Bacterial Agents; Brimonidine Tartrate; Cefazolin; Citrobacter koseri; Corneal Ulcer; Drug Therapy, Combination; Enterobacteriaceae Infections; Eye Infections, Bacterial; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Quinoxalines; Timolol | 2010 |
Brimonidine Protects Auditory Hair Cells from in vitro-Induced Toxicity of Gentamicin.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Gentamicins; Hair Cells, Auditory; MAP Kinase Signaling System; Neuroprotective Agents; Organ of Corti; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2 | 2017 |